Profil
Martin Everett worked as a Principal at Glaxo Smithkline Plc and the University of Birmingham.
He also worked as the Head-Research at MerLion Pharmaceuticals Pte Ltd.
Dr. Everett earned a doctorate degree from the University of Bristol in 1992 and an undergraduate degree from the University of Wales, Newport in 1987.
Ehemalige bekannte Positionen von Martin Everett
| Unternehmen | Position | Ende |
|---|---|---|
| Glaxo Smithkline Plc /Clinical Pharmacology Unit/ | Corporate Officer/Principal | - |
| University of Birmingham | Corporate Officer/Principal | - |
MerLion Pharmaceuticals Pte Ltd.
 MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Martin Everett
| University of Bristol | Doctorate Degree |
| University of Wales, Newport | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Glaxo Smithkline Plc /Clinical Pharmacology Unit/ | Commercial Services |
MerLion Pharmaceuticals Pte Ltd.
MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Commercial Services |
